MedTrace Logo

Intervention Trial Evaluating Focal Therapy Using High Intensity Focused Ultrasound for the Treatment of Prostate Cancer

NCT02265159 · Status: UNKNOWN · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2016-10-27

No results posted yet for this study

Summary

The investigators aim to evaluate cancer control, genitourinary, rectal and overall health-related quality of life outcomes and effectiveness of focal therapy for localised prostate cancer using High Intensity Focused Ultrasound (HIFU).

Conditions

Interventions

PROCEDURE

Focal Therapy Using High Intensity Focused Ultrasound

Sponsors & Collaborators

  • University College, London

    collaborator OTHER

  • University of Zurich

    lead OTHER

Principal Investigators

  • Daniel Eberli, PD Dr. PhD · Klinik für Urologie, Universitätsspital Zürich

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
99 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2020-05-31
Completion
2020-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02265159 on ClinicalTrials.gov